Healthcare - Medical - Devices - NASDAQ - US
$ 5.95
-7.32 %
$ 766 M
Market Cap
-74.37
P/E
Price Target
Average
89.08%
Revenue Forecast
Estimate
13.21%
EBIT
Estimate
31.24%
Net Income
Estimate
47.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytek Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CTKB of $11.2 , with forecasts ranging from a low of $8.5 to a high of $16 .
CTKB Lowest Price Target
Wall Street Target
8.5 USD
42.86%
CTKB Average Price Target
Wall Street Target
11.2 USD
89.08%
CTKB Highest Price Target
Wall Street Target
16 USD
168.91%
REVENUE FORECAST
Revenue Forecast Chart CTKB
EBIT FORECAST
EBIT Forecast Chart CTKB
NET INCOME FORECAST
Net Income Chart CTKB